Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outpatient Cervical Ripening with Misoprostol in Low-Risk Inductions After 39 Weeks Gestation: a Cost, Safety, and Satisfaction Analysis

NCT04041687 is registered in ClinicalTrials.gov with Prisma Health-Upstate as lead sponsor.

NCT NCT04041687
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04041687 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outpatient Cervical Ripening with Misoprostol in Low-Risk Inductions After 39 Weeks Gestation: a Cost, Safety, and Satisfaction Analysis
Lead sponsor
Prisma Health-Upstate
Phase
Observational
Overall status
Completed
Start date
June 1, 2019
Completion date
March 1, 2020
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pregnancy